MG
OACCW

Michael Gelband’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Michael Gelband’s Portfolio OACCW Stock Details OACCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.5K Hold
60,000
– – ﹤0.01% 1481
2026
Q1 		$45K Hold
60,000
– – ﹤0.01% 1462
2025
Q4 		$42.6K Hold
60,000
– – ﹤0.01% 1458
2025
Q3 		$45K Hold
60,000
– – ﹤0.01% 1456
2025
Q2 		$52K Hold
60,000
– – ﹤0.01% 1370
2025
Q1 		$45K Hold
60,000
– – ﹤0.01% 1373
2024
Q4 		$53K Buy
+60,000
New +$39.2K ﹤0.01% 1424

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Michael Gelband's OACCW Position: Q2 2026 in Review

Michael Gelband held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q2 2026 at 60,000 shares worth $56.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1481.

Michael Gelband first reported a position in OACCW in Q4 2024 and has held it in 7 quarters since. 27 funds tracked by Wall St. Rank hold OACCW as of Q2 2026.

  • Michael Gelband held 60,000 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $56.5K as of Q2 2026.
  • Michael Gelband left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1481 holding.
  • Michael Gelband first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2024 and has held it in 7 quarters since.
  • 27 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.